Company logo

Regeneron | Sustainability Performance

https://www.regeneron.com

Develops and markets pharmaceuticals and biologics for various medical conditions.

1924

United States

10,001+ employees

Pharmaceuticals

$10B+ in revenue

$1B - 10B in profitability

Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.

Sustainability Ranking & Industry Benchmark

#6501
Overallⓘ
#1406
in United Statesⓘ
#158
in Pharmaceuticalsⓘ

Sustainability Maturity

ⓘ

Sustainability Intent

ⓘ

Available in
Scale package

Access

Industry Rank

121 out of 287

Overview
Environmental
Carbon emissionsEnergy consumptionWaste ManagementWater ManagementNature and biodiversity
Social
Diversity and InclusionPay GapsHealth and SafetyExternalities
Governance
SDG Impact
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies

Company logo
Acer Therapeutics

United States, Health Care, Pharmaceuticals

Company logo
Intra-Cellular Therapies

United States, Health Care, Pharmaceuticals

Company logo
Parexel

United States, Health Care, Pharmaceuticals

CO2 scope 1 + 2 ⓘDirect emissions from owned or controlled sources, combined with indirect emissions from purchased electricity calculated using grid-average emission factors based on where the energy is consumed.
137.2KCO2e tonnes, 2024
Aligned
Renewable energy ⓘProportion of the company's total energy consumption sourced from renewable sources, expressed as a percentage.
8%2024
Critical
Waste generated ⓘTotal waste generated through the company's direct operations, including both hazardous and non-hazardous materials.
8.7Ktonnes, 2024
Leading
Female employees ⓘProportion of women in the company's total workforce, expressed as a percentage.
50%2024
Critical
Externalities ⓘThe monetized estimate of environmental and social impacts caused by an organization that are not reflected in its financial accounts.
9.3M$, 2024
Aligned
Market cap ⓘTotal market value of the company's outstanding shares, calculated by multiplying the share price by the number of shares outstanding.
63.2B$, 2026▼17.9% YoY
Revenue ⓘTotal revenue reported in the company's financial statements for the specified reporting year, reflecting income generated from primary business activities. Expressed in millions of USD.
14.3B$, 2025▼1% YoY
R&D intensity ⓘResearch and development expenditure expressed as a percentage of revenue, reflecting the company's relative investment in innovation.
36.35%2025

Intensity

Greenhouse gas intensity Scope 1, 2 (tCO₂e /$M)
Greenhouse gas intensity (Scope 1, 2, 3)(tCO₂e /$M)
Energy consumption (direct) intensity (MWh /$M)
Waste generation intensity (tonnes /$M)
Industry Benchmark

9.6

B/M 22.4

103.0

B/M 312.2

43.5

B/M 42.0

0.6

B/M 0.4


Powered by illuminem and GIST Impact

Controversy level

Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

 Available

Sustainability employees

ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.

Total sustainability employees

1

ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.

    Available in
    Scale package

    Access